Primary melanoma of the stomach treated by BRAF inhibitor and immunotherapy

Elena Bolzacchini, Graziella Pinotti(Medica (Italy)), Giordano Bernasconi(Ospedale di Circolo di Busto Arsizio), Ilaria Marcon(Ospedale di Circolo e Fondazione Macchi)

Digestive and Liver Disease

April 12, 2016

10.1016/j.dld.2016.04.002

Cited by 11

Related Papers

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

|New England Journal of Medicine|2014|751

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

|New England Journal of Medicine|2018|684

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

|The Lancet|2009|665

Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

|Blood|2003|490

Autografting Followed by Nonmyeloablative Immunosuppressive Chemotherapy and Allogeneic Peripheral-Blood Hematopoietic Stem-Cell Transplantation as Treatment of Resistant Hodgkin’s Disease and Non-Hodgkin’s Lymphoma

|Journal of Clinical Oncology|2000|228